# Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
Canonical URL: https://biopharmsignal.com/news/DERM/journey-medical-corporation-to-announce-third-quarter-2025-financial-results-on-november-12-2025
Ticker: DERM
Company: Journey Medical Corporation
Source: Journey Medical Corporation
Published: 2025-11-05 13:30 EST
Original Source URL: https://ir.journeymedicalcorp.com
## Article Body
No article body is available yet.
## Recent Company News
- 2026-05-19 20:45 EST — [Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference](https://biopharmsignal.com/news/DERM/journey-medical-corporation-to-participate-in-a-g-p-s-annual-virtual-healthcare-conference) — Source: Journey Medical Corporation
- 2026-05-13 20:01 EST — [Journey Medical Corporation Reports First Quarter 2026 Financial Results and Recent Corporate Highlights](https://biopharmsignal.com/news/DERM/journey-medical-corporation-reports-first-quarter-2026-financial-results-and-rec-ed65bf9d) — Source: Journey Medical Corporation
- 2026-05-06 20:01 EST — [Journey Medical Corporation to Announce First Quarter 2026 Financial Results on May 13, 2026](https://biopharmsignal.com/news/DERM/journey-medical-corporation-to-announce-first-quarter-2026-financial-results-on--4fe55408) — Source: Journey Medical Corporation
- 2026-04-21 12:30 EST — [Journey Medical Corporation Secures Contract with Third Major GPO for Emrosi™](https://biopharmsignal.com/news/DERM/journey-medical-corporation-secures-contract-with-third-major-gpo-for-emrositm) — Source: Journey Medical Corporation
- 2026-03-25 20:01 EST — [Journey Medical Corporation Reports Full-Year 2025 Financial Results and Recent Corporate Highlights](https://biopharmsignal.com/news/DERM/journey-medical-corporation-reports-full-year-2025-financial-results-and-recent--61ef9805) — Source: Journey Medical Corporation
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)
